Summit closes $500M raise, despite lower market cap; Revolution raises $300M in stock sale
Bob Duggan’s Summit Therapeutics has completed its $500 million raise — even though its market cap is short of that figure. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
